|
|
|
40
|
A3223
|
PAXIL 20MG TAB (GSK/COL) PAROXETINE
|
PAROXETINE
|
PAXIL
|
30'S
|
C
|
91.39
|
3.05
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A3223
|
PAXIL 20MG TAB (GSK) PAROXETINE (C)
|
PAROXETINE
|
PAXIL
|
30'S
|
C
|
100.5
|
3.3499
|
TAB
|
42
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
42
|
A3223
|
PAXIL 20MG TAB (GSK) PAROXETINE
|
PAROXETINE
|
PAXIL
|
30'S
|
C
|
105.55
|
3.52
|
TAB
|
42
|
BLIS
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
40
|
A3224
|
APO-CITALOPRAM 20MG TAB (APO/COL)
|
CITALOPRAM
|
APO-CITALOPRAM
|
30'S
|
A
|
6.80
|
0.23
|
TABLET
|
30
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A322AA
|
APO-SERTRALINE 50MG CAP (APO/COL)
|
SERTRALINE
|
APO-SERTRALINE
|
100'S
|
A
|
11.91
|
0.12
|
CAPSULE
|
30
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A322AF
|
ZOLOFT 50MG TAB (PFI/STO) SERTRALINE
|
SERTRALINE
|
ZOLOFT
|
14'S
|
C
|
19.49
|
1.39
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A322AF
|
ZOLOFT 50MG TAB (PFI) SERTRALINE (C)
|
SERTRALINE
|
ZOLOFT
|
14'S
|
C
|
19.68
|
1.4058
|
TAB
|
42
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
40
|
A322AQ
|
PAXIL CR 25MG TAB (GSK/COL) PAROXETINE
|
PAROXETINE
|
PAXIL CR
|
30'S
|
BP
|
91.39
|
3.05
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A322AQ
|
PAXIL 25MG CR TAB (GSK) PAROXETINE
|
PAROXETINE
|
PAXIL
|
30'S
|
BP
|
96.88
|
3.2294
|
TABCR
|
42
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
42
|
A322AQ
|
PAXIL 25MG CR TAB (GSK) PAROXETINE
|
PAROXETINE
|
PAXIL
|
30'S
|
C
|
101.75
|
3.39
|
TAB
|
42
|
BLIS
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
40
|
A322AY
|
ZOLOFT 100MG TAB (PFI/STO) SERTRALINE
|
SERTRALINE
|
ZOLOFT
|
14'S
|
C
|
29.25
|
2.09
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A322AY
|
ZOLOFT 100MG TAB (PFI) SERTRALINE (C)
|
SERTRALINE
|
ZOLOFT
|
14'S
|
C
|
29.49
|
2.1067
|
TAB
|
42
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
40
|
A322BB
|
PAXIL CR 12.5MG CAP (GSK/COL) PAROXETINE
|
PAROXETINE
|
PAXIL CR
|
30'S
|
BP
|
48.25
|
1.61
|
CAPSULE
|
0
|
CAP
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A322BB
|
PAXIL 12.5MG CR CAP (GSK) PAROXETINE (BP)
|
PAROXETINE
|
PAXIL
|
30'S
|
BP
|
51.4
|
1.7134
|
CAPCR
|
0
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
41
|
A322BT
|
VENLAFAXINE 150MG SR TAB (CIP) (BP)
|
VENLAFAXINE
|
VENLAFAXINE
|
100'S
|
BP
|
125.75
|
1.2575
|
TABSR
|
0
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE
|
|
|
|
|
42
|
A322BT
|
VENLAFAXINE 150MG SR TAB (CIP)
|
VENLAFAXINE
|
VENLAFAXINE
|
100'S
|
BP
|
128.03
|
1.28
|
TAB
|
0
|
BLIS
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE
|
|
|
|
|
41
|
A322BU
|
VENLAFAXINE 75MG SR TAB (CIP) (BP)
|
VENLAFAXINE
|
VENLAFAXINE
|
100'S
|
BP
|
64.42
|
0.6442
|
TABSR
|
0
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE
|
|
|
|
|
42
|
A322BU
|
VENLAFAXINE 75MG SR TAB (CIP)
|
VENLAFAXINE
|
VENLAFAXINE
|
100'S
|
BP
|
71.68
|
0.72
|
TAB
|
0
|
BLIS
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE
|
|
|
|
|
40
|
A322CJ
|
APO-SERTRALINE 100MG CAP (APO/COL)
|
SERTRALINE
|
APO-SERTRALINE
|
100'S
|
A
|
19.03
|
0.19
|
CAPSULE
|
30
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
A322CJ
|
APO-SERTRALINE 100MG CAP (APO)
|
SERTRALINE
|
APO-SERTRALINE
|
100'S
|
A
|
19.41
|
0.19
|
CAP
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|